Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bio-Rad Laboratories (BIO)

Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,888,030
  • Shares Outstanding, K 26,975
  • Annual Sales, $ 2,567 M
  • Annual Income, $ -1,844 M
  • EBIT $ 304 M
  • EBITDA $ 304 M
  • 60-Month Beta 1.18
  • Price/Sales 3.15
  • Price/Cash Flow 28.26
  • Price/Book 1.18

Options Overview Details

View History
  • Implied Volatility 41.29% (-18.41%)
  • Historical Volatility 41.48%
  • IV Percentile 71%
  • IV Rank 37.38%
  • IV High 64.21% on 04/08/25
  • IV Low 27.60% on 08/25/25
  • Expected Move (DTE 7) 16.61 (6.36%)
  • Put/Call Vol Ratio 2.49
  • Today's Volume 157
  • Volume Avg (30-Day) 263
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 2,916
  • Open Int (30-Day) 735
  • Expected Range 244.66 to 277.88

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 2.79
  • Number of Estimates 1
  • High Estimate 2.79
  • Low Estimate 2.79
  • Prior Year 2.54
  • Growth Rate Est. (year over year) +9.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
251.00 +4.18%
on 02/13/26
325.93 -19.77%
on 01/14/26
-60.67 (-18.83%)
since 01/13/26
3-Month
251.00 +4.18%
on 02/13/26
334.53 -21.83%
on 11/25/25
-55.39 (-17.48%)
since 11/13/25
52-Week
211.43 +23.68%
on 06/03/25
343.12 -23.79%
on 10/27/25
-44.86 (-14.64%)
since 02/13/25

Most Recent Stories

More News
Stocks Recover as Chipmakers Rebound

The S&P 500 Index ($SPX ) (SPY ) today is up +0.18%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.23%. March E-mini S&P futures (ESH26...

MSTR : 132.97 (+8.11%)
AMAT : 359.62 (+9.51%)
ROKU : 87.18 (+5.12%)
ANET : 145.13 (+7.41%)
GLXY : 21.44 (+6.40%)
EXPE : 213.05 (-6.24%)
RIVN : 17.28 (+23.43%)
ABNB : 120.46 (+3.88%)
$IUXX : 24,776.11 (+0.36%)
TPH : 46.33 (+26.69%)
COIN : 163.46 (+15.86%)
ASML : 1,418.24 (+0.81%)
Stocks Edge Lower as AI Fears Linger

The S&P 500 Index ($SPX ) (SPY ) today is down -0.22%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.23%. March E-mini S&P futures...

GOOGL : 305.86 (-1.02%)
AMAT : 359.62 (+9.51%)
ROKU : 87.18 (+5.12%)
AAPL : 259.46 (-0.87%)
ANET : 145.13 (+7.41%)
ADI : 335.51 (+1.25%)
EXPE : 213.05 (-6.24%)
RIVN : 17.28 (+23.43%)
ABNB : 120.46 (+3.88%)
$IUXX : 24,776.11 (+0.36%)
TPH : 46.33 (+26.69%)
ZNH26 : 113-050 (+0.32%)
Bio-Rad: Q4 Earnings Snapshot

Bio-Rad: Q4 Earnings Snapshot

BIO : 258.16 (-11.72%)
Bio-Rad: Q4 Earnings Snapshot

Bio-Rad: Q4 Earnings Snapshot

BIO : 258.16 (-11.72%)
Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the fourth quarter and full-year ended...

BIO : 258.16 (-11.72%)
Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the fourth quarter and full year 2025...

BIO : 258.16 (-11.72%)
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company's Chief Executive Officer Norman Schwartz,...

BIO : 258.16 (-11.72%)
Bio-Rad: Q3 Earnings Snapshot

Bio-Rad: Q3 Earnings Snapshot

BIO : 258.16 (-11.72%)
Bio-Rad: Q3 Earnings Snapshot

Bio-Rad: Q3 Earnings Snapshot

BIO : 258.16 (-11.72%)
Bio-Rad Reports Third-Quarter 2025 Financial Results

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the third quarter ended September 30,...

BIO : 258.16 (-11.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

Relative Strength just crossed below 30%. The market has entered oversold territory.

See More Share

Business Summary

Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and...

See More

Key Turning Points

3rd Resistance Point 311.97
2nd Resistance Point 304.15
1st Resistance Point 298.29
Last Price 258.16
1st Support Level 284.61
2nd Support Level 276.79
3rd Support Level 270.93

See More

52-Week High 343.12
Fibonacci 61.8% 292.81
Fibonacci 50% 277.27
Fibonacci 38.2% 261.74
Last Price 258.16
52-Week Low 211.43

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar